Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

August 2012 - FRMC

Physicians Surveyed about Strategies to Contain Costs
08/14/2013
Tori Socha
Tori Socha
Strategies suggested to curb increasing healthcare costs in the United States often focus on physicians, calling for reductions in waste and increased conservative stewardship of resources. Noting the importance of physicians’ perspectives on...
Strategies suggested to curb increasing healthcare costs in the United States often focus on physicians, calling for reductions in waste and increased conservative stewardship of resources. Noting the importance of physicians’ perspectives on...
Strategies suggested to curb...
08/14/2013
First Report Managed Care
MEK Inhibition in BRAF-Mutated Melanoma
08/16/2012
Kevin L. Carter
Kevin L. Carter
Until recently, there was no systemic therapy shown to improve overall survival among patients with metastatic melanoma, and only modest improvements were observed with interferon as an adjuvant drug. Ipilimumab, a monoclonal antibody...
Until recently, there was no systemic therapy shown to improve overall survival among patients with metastatic melanoma, and only modest improvements were observed with interferon as an adjuvant drug. Ipilimumab, a monoclonal antibody...
Until recently, there was no...
08/16/2012
First Report Managed Care
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
08/16/2012
Kevin L. Carter
Kevin L. Carter
The 5-year survival rate for adrenocortical carcinoma, a rare cancer with a poor prognosis, is <15% among patients with metastatic disease. Mitotane is the only drug approved for the treatment of adrenocortical carcinoma and is used both...
The 5-year survival rate for adrenocortical carcinoma, a rare cancer with a poor prognosis, is <15% among patients with metastatic disease. Mitotane is the only drug approved for the treatment of adrenocortical carcinoma and is used both...
The 5-year survival rate for...
08/16/2012
First Report Managed Care
Rapid Whole-Genome Sequencing in a Neonatal MRSA Outbreak
08/16/2012
Kevin L. Carter
Kevin L. Carter
Although rapid whole-genome sequencing has been successfully used as a research tool with discriminatory power in outbreaks, it is also potentially useful for its possible clinical utility in a diagnostic setting. A compelling target is...
Although rapid whole-genome sequencing has been successfully used as a research tool with discriminatory power in outbreaks, it is also potentially useful for its possible clinical utility in a diagnostic setting. A compelling target is...
Although rapid whole-genome...
08/16/2012
First Report Managed Care
Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
08/16/2012
Kevin L. Carter
Kevin L. Carter
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of...
08/16/2012
First Report Managed Care
Patterns of Antiamyloid-β Antibodies in Typical and Atypical Alzheimer Disease
08/16/2012
Kevin L. Carter
Kevin L. Carter
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer...
08/16/2012
First Report Managed Care
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
08/16/2012
Kevin L. Carter
Kevin L. Carter
Thyroid cancer is the most common endocrine cancer, with >48,000 new cases occurring each year in the United States. Most cases are differentiated thyroid cancer, which is associated with a high 10-year survival rate of 90% to 95%. Many...
Thyroid cancer is the most common endocrine cancer, with >48,000 new cases occurring each year in the United States. Most cases are differentiated thyroid cancer, which is associated with a high 10-year survival rate of 90% to 95%. Many...
Thyroid cancer is the most...
08/16/2012
First Report Managed Care
Short Sleep Duration and Risk for Strokes
08/16/2012
Tim Casey
Tim Casey
Boston—Researchers found an association between adults of normal weight sleeping <6 hours per night and an increased risk of stroke symptoms, according to an analysis of 5666 people who were part of a large study that has tracked patients...
Boston—Researchers found an association between adults of normal weight sleeping <6 hours per night and an increased risk of stroke symptoms, according to an analysis of 5666 people who were part of a large study that has tracked patients...
Boston—Researchers found an...
08/16/2012
First Report Managed Care
Zolpidem Tartrate Sublingual Tablets to Treat Insomnia
08/16/2012
Tim Casey
Tim Casey
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc analysis of a double-blind, placebo-controlled cross-over study, patients who took 1.75 mg and 3.5 mg of zolpidem tartrate sublingual tablets had a significantly shorter time to sleep compared with those who...
Boston—According to a post hoc...
08/16/2012
First Report Managed Care
Aggressive BP Treatment Has No Benefit in Cardiovascular Disease Risk
08/16/2012
Tim Casey
Tim Casey
Philadelphia—A subanalysis of a major randomized blood pressure trial found that patients who are centrally obese and have type 2 diabetes do not benefit in terms of cardiovascular disease risk when they are treated aggressively to lower...
Philadelphia—A subanalysis of a major randomized blood pressure trial found that patients who are centrally obese and have type 2 diabetes do not benefit in terms of cardiovascular disease risk when they are treated aggressively to lower...
Philadelphia—A subanalysis of a...
08/16/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Payers Spend Less For Chemotherapy in Physician Offices VS Hospitals
02/28/2018
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that...
02/28/2018
First Report Managed Care
News
Medicare physician pay cut reversal in Senate`s hands
06/07/2010
06/07/2010
First Report Managed Care
Choosing Therapy for Type 2 Diabetes Based on Patient-Related Variables
06/10/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability...
06/10/2015
First Report Managed Care
News
Health Insurers Seek Delay Of New Consumer-Friendly Coverage Forms
08/23/2011
08/23/2011
First Report Managed Care
News
Adjuvant Therapy Tied to Better Survival in High-Risk Merkel Cell Carcinoma
12/11/2014
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is...
12/11/2014
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

August 2012 Volume 9 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement